Reduced SMAD7 Leads to Overactivation of TGF-β Signaling in MDS that Can Be Reversed by a Specific Inhibitor of TGF-β Receptor I Kinase

Li Zhou(Harbin Institute of Technology), Amit Verma(M.J.P. Rohilkhand University)
Cancer Research
December 29, 2010
Cited by 132


Related Papers